6 sources checked · 2 source groups included · 2h ago
Still Watching
Astra Zeneca holds talks with Bristol Myers Squibb over $400bn tie-up
The Guardian - Business and Market Watch describe the same event in different terms.
2 Left4 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 3, 2026 at 10:43 AM, this is how Optics News reads the wording differences in this story.
What happenedDeal would create world’s fourth-largest drugmaker by market value.
The headline splitThe left frames it as "Astra Zeneca holds talks with Bristol Myers Squibb on $400bn merger". The center frames it as "Astra Zeneca in talks over potential Bristol-Myers Squibb megadeal that would create worl...".
Match confidenceMedium confidence. 6 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
6 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
65/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftAstra Zeneca in talks over £300bn mega-merger with US rival – reports
The Independent · Center-left · News report
CenterAstra Zeneca holds talks with Bristol Myers Squibb over $400bn tie-up
Financial Times · Center · News report
Right / center-rightNo matching source in this bucket yet.
Astra Zeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
Astra Zeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come tog...
Astra Zeneca holds talks with Bristol Myers Squibb on $400bn merger
Tie-up would be one of the biggest-ever pharmaceutical deals and create the world’s fourth-largest drugmaker Business live – latest updates Britain’s biggest drugmaker, Astra Zeneca, is und...